Li W, Zhang Z, Kumar S, Botey-Bataller J, Zoodsma M, Ehsani A
Nat Aging. 2025; .
PMID: 40044970
DOI: 10.1038/s43587-025-00819-z.
De Voss C, Korompis M, Li S, Ateere A, McShane H, Stylianou E
Front Immunol. 2025; 16:1540359.
PMID: 40018046
PMC: 11865049.
DOI: 10.3389/fimmu.2025.1540359.
Dong S, Shi X, Wu X, Yi F
J Inflamm Res. 2025; 18:2521-2530.
PMID: 39995824
PMC: 11849421.
DOI: 10.2147/JIR.S496037.
Dillon N, Lamont E, Rather M, Baughn A
bioRxiv. 2025; .
PMID: 39763714
PMC: 11702753.
DOI: 10.1101/2024.12.17.628853.
Lyu J, Narum D, Baldwin S, Larsen S, Bai X, Griffith D
Front Immunol. 2024; 15:1427559.
PMID: 39717773
PMC: 11663721.
DOI: 10.3389/fimmu.2024.1427559.
Leveraging computer-aided design and artificial intelligence to develop a next-generation multi-epitope tuberculosis vaccine candidate.
Zhuang L, Ali A, Yang L, Ye Z, Li L, Ni R
Infect Med (Beijing). 2024; 3(4):100148.
PMID: 39687693
PMC: 11647498.
DOI: 10.1016/j.imj.2024.100148.
MTBVAC induces superior antibody titers and IgG avidity compared to BCG vaccination in non-human primates.
Peralta-Alvarez M, Downward K, White A, Azema H, Sibley L, Sarfas C
NPJ Vaccines. 2024; 9(1):230.
PMID: 39567530
PMC: 11579480.
DOI: 10.1038/s41541-024-01009-5.
Immune correlates of protection as a game changer in tuberculosis vaccine development.
Wang J, Fan X, Hu Z
NPJ Vaccines. 2024; 9(1):208.
PMID: 39478007
PMC: 11526030.
DOI: 10.1038/s41541-024-01004-w.
Impact of diabetes mellitus on tuberculosis prevention, diagnosis, and treatment from an immunologic perspective.
Ye Z, Li L, Yang L, Zhuang L, Aspatwar A, Wang L
Exploration (Beijing). 2024; 4(5):20230138.
PMID: 39439490
PMC: 11491313.
DOI: 10.1002/EXP.20230138.
Effects of dietary Lactobacillus postbiotics and bacitracin on the modulation of mucosa-associated microbiota and pattern recognition receptors affecting immunocompetence of jejunal mucosa in pigs challenged with enterotoxigenic F18 Escherichia....
Duarte M, Deng Z, Kim S
J Anim Sci Biotechnol. 2024; 15(1):139.
PMID: 39390608
PMC: 11468193.
DOI: 10.1186/s40104-024-01098-1.
Increased serum interferon activity in sarcoidosis compared to that in tuberculosis: Implication for diagnosis?.
Schrijver B, Gopfert J, La Distia Nora R, Putera I, Nagtzaam N, Smits Te Nijenhuis M
Heliyon. 2024; 10(18):e37103.
PMID: 39309852
PMC: 11416298.
DOI: 10.1016/j.heliyon.2024.e37103.
Clinical characteristics and pregnancy outcomes in pregnant women with TB: a retrospective cohort study.
Wen J, He J
Ann Med. 2024; 56(1):2401108.
PMID: 39268596
PMC: 11404374.
DOI: 10.1080/07853890.2024.2401108.
Enhancement of mycobacterial pathogenesis by host interferon-γ.
Hop H, Liao P, Wu H
Cell Mol Life Sci. 2024; 81(1):380.
PMID: 39222120
PMC: 11368887.
DOI: 10.1007/s00018-024-05425-7.
Anti-Interferon-γ Therapy for Cytokine Storm Syndromes.
Behrens E, De Benedetti F
Adv Exp Med Biol. 2024; 1448:573-582.
PMID: 39117840
DOI: 10.1007/978-3-031-59815-9_38.
Mitochondrial Transplantation Promotes Protective Effector and Memory CD4 T Cell Response During Mycobacterium Tuberculosis Infection and Diminishes Exhaustion and Senescence in Elderly CD4 T cells.
Headley C, Gautam S, Olmo-Fontanez A, Garcia-Vilanova A, Dwivedi V, Schami A
Adv Sci (Weinh). 2024; 11(36):e2401077.
PMID: 39039808
PMC: 11423092.
DOI: 10.1002/advs.202401077.
Host and pathogen genetic diversity shape vaccine-mediated protection to .
Cohen S, Plumlee C, Engels L, Mai D, Murray T, Jahn A
Front Immunol. 2024; 15:1427846.
PMID: 39007152
PMC: 11239334.
DOI: 10.3389/fimmu.2024.1427846.
Agent-based model predicts that layered structure and 3D movement work synergistically to reduce bacterial load in 3D in vitro models of tuberculosis granuloma.
Petrucciani A, Hoerter A, Kotze L, Plessis N, Pienaar E
PLoS Comput Biol. 2024; 20(7):e1012266.
PMID: 38995971
PMC: 11288457.
DOI: 10.1371/journal.pcbi.1012266.
Mycobacterium tuberculosis strain with deletions in menT3 and menT4 is attenuated and confers protection in mice and guinea pigs.
Gosain T, Chugh S, Rizvi Z, Chauhan N, Kidwai S, Thakur K
Nat Commun. 2024; 15(1):5467.
PMID: 38937463
PMC: 11211403.
DOI: 10.1038/s41467-024-49246-5.
Therapeutic Modulation of Arginase with nor-NOHA Alters Immune Responses in Experimental Mouse Models of Pulmonary Tuberculosis including in the Setting of Human Immunodeficiency Virus (HIV) Co-Infection.
Chauhan S, Nusbaum R, Huante M, Holloway A, Endsley M, Gelman B
Trop Med Infect Dis. 2024; 9(6).
PMID: 38922041
PMC: 11209148.
DOI: 10.3390/tropicalmed9060129.
Reappraising the Role of T Cell-Derived IFN-γ in Restriction of Mycobacterium tuberculosis in the Murine Lung.
Maciag K, Plumlee C, Cohen S, Gern B, Urdahl K
J Immunol. 2024; 213(3):339-346.
PMID: 38912839
PMC: 11249196.
DOI: 10.4049/jimmunol.2400145.